---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-032601"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2026-10-14T12:43:34+00:00"
generated_at: "2026-10-14T12:45:05.596350+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences, Clayman Thyroid Center announce nPulse Vybrance commercial and clinical partnership

## Summary
- Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa, Florida is now treating patients with the nPulse Vybrance Percutaneous Electrode System for symptomatic benign thyroid nodules.
- Clayman is the only site in the Tampa Bay Area offering nPulse technology; the rollout is part of Pulse Biosciences' controlled market development strategy.
- Clinical collaboration covers real-world outcomes collection and formal studies of nsPFA energy in benign thyroid nodule treatment; no financial terms disclosed.
- CEO Paul LaViolette said Clayman is one of the largest thyroid surgery centers nationally with significant regional and national referral patterns.
- Vybrance delivers nonthermal nanosecond pulsed field ablation under ultrasound guidance; patients go home same day and symptoms typically ease within weeks.

## SEC filing metadata
- accession: 0001437749-26-032601
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2026-10-14T12:43:34+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774926032601/0001437749-26-032601-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926032601/plse20261013_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-032601
- JSON: https://secwatch.observer/filing/0001437749-26-032601.json
- Plain text: https://secwatch.observer/filing/0001437749-26-032601.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.